Cytogen, Neoprobe deal

CYTO's Cellcor subsidiary (Newton, Mass.) will manufacture RIGS/ACT, NEOP's activated cell therapy product to treat metastatic colorectal cancer. Cellcor will receive an up front fee and will record contract revenue on a per patient basis. ...